Selective Blockade of the Sigma 1 Receptor Has Beneficial Effects on Both Acute and Chronic Oxaliplatin-Induced Peripheral Neuropathy
Date
2018Journal
NeurotherapeuticsPublisher
Springer New York LLCType
Note
Metadata
Show full item recordKeyword
chemotherapy-induced peripheral neuropathyColorectal Neoplasms--drug therapy
Molecular Chaperones--antagonists & inhibitors
Oxaliplatin--adverse effects
Peripheral Nervous System Diseases
Identifier to cite or link to this item
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85033470294&doi=10.1007%2fs13311-017-0584-1&partnerID=40&md5=d41c8613c997dab8290d92a69e59b79c; http://hdl.handle.net/10713/8766ae974a485f413a2113503eed53cd6c53
10.1007/s13311-017-0584-1
Scopus Count
Collections
Related articles
- Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial.
- Authors: Bruna J, Videla S, Argyriou AA, Velasco R, Villoria J, Santos C, Nadal C, Cavaletti G, Alberti P, Briani C, Kalofonos HP, Cortinovis D, Sust M, Vaqué A, Klein T, Plata-Salamán C
- Issue date: 2018 Jan
- The incidence of acute oxaliplatin-induced neuropathy and its impact on treatment in the first cycle: a systematic review.
- Authors: Gebremedhn EG, Shortland PJ, Mahns DA
- Issue date: 2018 Apr 12
- The preliminary effects of henna on chemotherapy-induced peripheral neuropathy in women receiving oxaliplatin-based treatment: A parallel-group, randomized, controlled pilot trial.
- Authors: Arslan S, Zorba Bahceli P, İlik Y, Artaç M
- Issue date: 2020 Oct
- Oxaliplatin-induced peripheral neuropathy risk factors and management in Tunisian population.
- Authors: Zribi A, Nasr SB, Hamdi S, Ayari J, Fendri S, Balti M, Haddaoui A
- Issue date: 2020
- A-Fibers Mediate Cold Hyperalgesia in Patients with Oxaliplatin-Induced Neuropathy.
- Authors: Forstenpointner J, Oberlojer VC, Naleschinski D, Höper J, Helfert SM, Binder A, Gierthmühlen J, Baron R
- Issue date: 2018 Jul